Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome

NCT02446730 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1400

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Death
Hemorrhage
Cerebrovascular Accident
Myocardial Infarction

Interventions

DEVICE: BES (biodegradable polymer biolimus-eluting stent)
DRUG: Prasugel
DRUG: Clopidogrel

Sponsor

Chonnam National University Hospital